![]() |
![]() |
Legal status
Patent expired
(51) | INT.CL. | C07D 403/12 | (2006.01) |
A61K 31/505 | (2006.01) | ||
A61P 35/00 | (2006.01) |
(11) | Number of the document | 1699782 |
(13) | Kind of document | T |
(96) | European patent application number | 04806159.2 |
Date of filing the European patent application | 2004-12-18 | |
(97) | Date of publication of the European application | 2006-09-13 |
(45) | Date of publication and mention of the grant of the patent | 2010-06-23 |
(46) | Date of publication of the claims translation | 2010-09-29 |
(86) | Number | PCT/GB2004/005359 |
Date | 2004-12-18 |
(87) | Number | WO 2005/061488 |
Date | 2005-07-07 |
(30) | Number | Date | Country code |
0330002 | 2003-12-24 | GB |
(72) |
McCABE, James, GB
|
(73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
(74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
(54) | Chinazolino darinio maleato druskos, naudingos kaip antiangiogeninis agentas |
MALEATE SALTS OF A QUINAZOLINE DERIVATIVE USEFUL AS AN ANTIANGIOGENIC AGENT |
Payment date | Validity (years) | Amount | |
2023-11-27 | 347.00 EUR |